Riente L. The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis. Reumatismo [Internet]. 2004 Mar. 30 [cited 2024 Dec. 28];56(s1):74-9. Available from: https://www.reumatismo.org/reuma/article/view/reumatismo.2004.1s.74